Morgan Stanley Quotient LTD Transaction History

Morgan Stanley

$1.39 Trillion
Q4 2024

Shares

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2022 Nov 14, 2022	SELL	$0.16 - $0.31 $2,275 - $4,409	-14,224 Reduced 4.74%	285,831 $43,000
Q2 2022 Oct 27, 2022	SELL	$0.24 - $1.2 $1.09 Million - $5.44 Million	-4,531,497 Reduced 93.79%	300,055 $71,000
Q2 2022 Aug 15, 2022	SELL	$0.24 - $1.2 $1.09 Million - $5.44 Million	-4,531,497 Reduced 93.79%	300,055 $71,000
Q1 2022 Oct 27, 2022	BUY	$0.94 - $2.38 $4.26 Million - $10.8 Million	4,531,497 Added 1510.22%	4,831,552 $5.8 Million
Q1 2022 May 13, 2022	BUY	$0.94 - $2.38 $1.04 Million - $2.64 Million	1,108,501 Added 29.77%	4,831,552 $5.8 Million
Q4 2021 Feb 14, 2022	BUY	$1.89 - $3.12 $358,935 - $592,528	189,913 Added 5.38%	3,723,051 $9.64 Million
Q3 2021 Nov 15, 2021	BUY	$2.34 - $3.77 $8.27 Million - $13.3 Million	3,533,138 New	3,533,138 $8.27 Million

Others Institutions Holding QTNT

# of Institutions

1

Shares Held

1.71K

Call Options Held

0

Put Options Held

0

Brewin Dolphin LTD London, X0

1.71K
Shares

$68
0.0% of portfolio

About Quotient Ltd

Ticker QTNT
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Description
Quotient Limited, a commercial-stage diagnostics company, develops, manufactures, commercializes, and sells products for the global transfusion diagnostics market in the United States, France, Japan, and internationally. The company is developing MosaiQ, a proprietary technology platform, which provides tests for immunohematology, serological di...

More about QTNT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.